CD44 and cancer: Mechanistically, the ESRP1-mediated alternative splicing of the CD44 mRNA stimulates the cystine transporter (x-CT), which is involved in cysteine uptake and the accumulation of reductive glutathione (GSH); this decreases ROS and thereby prevents cancer cell metastasis [60].